Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
vaccine was given part 2 with a sterile diluent and not part one; vaccine was given part 2 with a sterile diluent and not part one; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of wrong solution used in drug reconstitution in a patient who received Herpes zoster (Herpes Zoster vaccine) for prophylaxis. On an unknown date, the patient received Herpes Zoster vaccine. On an unknown date, an unknown time after receiving Herpes Zoster vaccine, the patient experienced wrong solution used in drug reconstitution (Verbatim: vaccine was given part 2 with a sterile diluent and not part one) and inappropriate dose of vaccine administered (Verbatim: vaccine was given part 2 with a sterile diluent and not part one). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 19-AUG-2025 This case was reported by a patient via interactive digital media. The second part of the zoster vaccine was administered with a sterile diluent instead of the first part. To proceed, part one needed to be given separately, and it required reconstitution with the appropriate sterile diluent before administration.